Levi Strauss (LEVI) insider filing shows DER grants and holdings
Rhea-AI Filing Summary
Levi Strauss & Co. (LEVI) disclosed a Form 4 for a director reporting equity grants on 11/04/2025. The filing shows the acquisition of 85 shares of Class A Common Stock at $0.00, reported as dividend equivalent rights (DERs). Following this transaction, 122,701 Class A shares were beneficially owned on a direct basis.
The filing also reports 331 derivative securities acquired at $0.00, described as DERs that convey a contingent right to receive one share upon settlement; certain DERs are fully vested with a deferral delivery feature. Each share of Class B Common Stock is convertible into one Class A share at the holder’s option and has no expiration date. Derivative securities beneficially owned following the reported transactions totaled 46,500.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class B Common Stock | 331 | $0.00 | -- |
| Grant/Award | Class A Common Stock | 85 | $0.00 | -- |
Footnotes (1)
- Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature.